Clinical and Economic Assessment of Robot-Assisted Radical Prostatectomy With the Hinotori Surgical System: Insights From a Japanese Single-Centre Study

IF 2.3 3区医学 Q2 SURGERY

International Journal of Medical Robotics and Computer Assisted Surgery Pub Date : 2025-06-21 DOI:10.1002/rcs.70084

Kotaro Obayashi, Jun Akatsuka, Takuya Nishino, Mami Takadate, Hiroya Hasegawa, Hikaru Mikami, Hayato Takeda, Yuki Endo, Yuka Toyama, Takeshi Yamada, Yoichiro Yamamoto, Go Kimura, Yukihiro Kondo

{"title":"Clinical and Economic Assessment of Robot-Assisted Radical Prostatectomy With the Hinotori Surgical System: Insights From a Japanese Single-Centre Study","authors":"Kotaro Obayashi, Jun Akatsuka, Takuya Nishino, Mami Takadate, Hiroya Hasegawa, Hikaru Mikami, Hayato Takeda, Yuki Endo, Yuka Toyama, Takeshi Yamada, Yoichiro Yamamoto, Go Kimura, Yukihiro Kondo","doi":"10.1002/rcs.70084","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>We investigated the clinical and economic outcomes of robot-assisted radical prostatectomy (RARP) using the hinotori surgical system (H-RARP).</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>The analysis was conducted on 76 and 68 patients who underwent RARP using the da Vinci surgical system (D-RARP) and H-RARP, respectively. Safety, oncological, and functional outcomes were compared between H-RARP and D-RARP. Risk factors influencing medical costs in RARP were identified via linear regression analysis.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Except for longer operative time in H-RARP, clinical outcomes were comparable. The median medical costs per case were $12,426.8 for D-RARP and $12,548.9 for H-RARP. Operative time (coefficient: 0.0002, <i>p</i> < 0.001), pathological T stage (coefficient: 0.023, <i>p</i> = 0.030), and postoperative hospital stay (coefficient: 0.028, <i>p</i> < 0.001) were significant factors affecting medical costs; in contrast, the type of robot-assisted surgical system was not a significant factor.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>H-RARP offers clinical outcomes comparable to those of D-RARP while maintaining equivalent medical costs.</p>\n </section>\n </div>","PeriodicalId":50311,"journal":{"name":"International Journal of Medical Robotics and Computer Assisted Surgery","volume":"21 3","pages":""},"PeriodicalIF":2.3000,"publicationDate":"2025-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/rcs.70084","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Medical Robotics and Computer Assisted Surgery","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/rcs.70084","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"SURGERY","Score":null,"Total":0}

引用次数: 0

Abstract

Background

We investigated the clinical and economic outcomes of robot-assisted radical prostatectomy (RARP) using the hinotori surgical system (H-RARP).

Methods

The analysis was conducted on 76 and 68 patients who underwent RARP using the da Vinci surgical system (D-RARP) and H-RARP, respectively. Safety, oncological, and functional outcomes were compared between H-RARP and D-RARP. Risk factors influencing medical costs in RARP were identified via linear regression analysis.

Results

Except for longer operative time in H-RARP, clinical outcomes were comparable. The median medical costs per case were $12,426.8 for D-RARP and $12,548.9 for H-RARP. Operative time (coefficient: 0.0002, p < 0.001), pathological T stage (coefficient: 0.023, p = 0.030), and postoperative hospital stay (coefficient: 0.028, p < 0.001) were significant factors affecting medical costs; in contrast, the type of robot-assisted surgical system was not a significant factor.

Conclusions

H-RARP offers clinical outcomes comparable to those of D-RARP while maintaining equivalent medical costs.

查看原文本刊更多论文

机器人辅助根治性前列腺切除术与Hinotori手术系统的临床和经济评估：来自日本单中心研究的见解

我们研究了使用hinotori手术系统（H-RARP）的机器人辅助根治性前列腺切除术（RARP）的临床和经济效果。方法对76例和68例采用达芬奇手术系统（D-RARP）行RARP的患者进行分析。比较了H-RARP和D-RARP的安全性、肿瘤学和功能结果。通过线性回归分析确定影响RARP医疗费用的危险因素。结果除H-RARP手术时间较长外，两组临床结果具有可比性。每例D-RARP患者的平均医疗费用为12426.8美元，H-RARP患者的平均医疗费用为12548.9美元。操作时间(系数：0.0002,p <；0.001)、病理T分期（系数：0.023,p = 0.030）、术后住院时间(系数：0.028,p <；0.001)是影响医疗费用的显著因素；相比之下，机器人辅助手术系统的类型并不是一个重要因素。结论H-RARP的临床效果与D-RARP相当，同时保持相同的医疗费用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

International Journal of Medical Robotics and Computer Assisted Surgery 医学-外科

CiteScore

4.50

自引率

12.00%

发文量

131

审稿时长

6-12 weeks

期刊介绍： The International Journal of Medical Robotics and Computer Assisted Surgery provides a cross-disciplinary platform for presenting the latest developments in robotics and computer assisted technologies for medical applications. The journal publishes cutting-edge papers and expert reviews, complemented by commentaries, correspondence and conference highlights that stimulate discussion and exchange of ideas. Areas of interest include robotic surgery aids and systems, operative planning tools, medical imaging and visualisation, simulation and navigation, virtual reality, intuitive command and control systems, haptics and sensor technologies. In addition to research and surgical planning studies, the journal welcomes papers detailing clinical trials and applications of computer-assisted workflows and robotic systems in neurosurgery, urology, paediatric, orthopaedic, craniofacial, cardiovascular, thoraco-abdominal, musculoskeletal and visceral surgery. Articles providing critical analysis of clinical trials, assessment of the benefits and risks of the application of these technologies, commenting on ease of use, or addressing surgical education and training issues are also encouraged. The journal aims to foster a community that encompasses medical practitioners, researchers, and engineers and computer scientists developing robotic systems and computational tools in academic and commercial environments, with the intention of promoting and developing these exciting areas of medical technology.